Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,264 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons.
Kelley CF, Acevedo-Quiñones M, Agwu AL, Avihingsanon A, Benson P, Blumenthal J, Brinson C, Brites C, Cahn P, Cantos VD, Clark J, Clement M, Creticos C, Crofoot G, Diaz RS, Doblecki-Lewis S, Gallardo-Cartagena JA, Gaur A, Grinsztejn B, Hassler S, Hinojosa JC, Hodge T, Kaplan R, Lacerda M, LaMarca A, Losso MH, Valdez Madruga J, Mayer KH, Mills A, Mounzer K, Ndlovu N, Novak RM, Perez Rios A, Phanuphak N, Ramgopal M, Ruane PJ, Sánchez J, Santos B, Schine P, Schreibman T, Spencer LY, Van Gerwen OT, Vasconcelos R, Vasquez JG, Zwane Z, Cox S, Deaton C, Ebrahimi R, Wong P, Singh R, Brown LB, Carter CC, Das M, Baeten JM, Ogbuagu O; PURPOSE 2 Study Team. Kelley CF, et al. Among authors: mayer kh. N Engl J Med. 2024 Nov 27. doi: 10.1056/NEJMoa2411858. Online ahead of print. N Engl J Med. 2024. PMID: 39602624
Preference for Long-Acting HIV Prevention Methods Among Transgender Women Vulnerable to HIV in Eastern and Southern United States: Findings from the LITE Study.
Cooney EE, Stevenson M, Aguayo-Romero RA, Valera G, Poteat TC, Mayer KH, Beyrer C, Althoff KN, Radix AE, Wawrzyniak AJ, Cannon CM, Schneider JS, Brown CA, Vannappagari V, Ragone L, de Ruiter A, Reisner SL, Wirtz AL. Cooney EE, et al. Among authors: mayer kh. AIDS Behav. 2024 Dec 5. doi: 10.1007/s10461-024-04561-2. Online ahead of print. AIDS Behav. 2024. PMID: 39636555
Why is roll-out of long-acting PrEP agents so slow?
Patel RR, Mayer KH. Patel RR, et al. Among authors: mayer kh. Curr Opin HIV AIDS. 2025 Jan 1;20(1):48-53. doi: 10.1097/COH.0000000000000899. Epub 2024 Nov 14. Curr Opin HIV AIDS. 2025. PMID: 39633538 Review.
Correction: Severity and Number of Substances Used are Independently Associated with Antiretroviral Therapy Adherence Over Time Among People with HIV in the Current Treatment Era.
Ma J, Delaney JAC, Ruderman SA, Nance RM, Hahn AW, Drumright LN, Whitney BM, Fredericksen RJ, Mixson LS, Merrill JO, Safren SA, Mayer KH, O'Cleirigh C, Napravnik S, Chander G, Moore RD, Christopoulos KA, Willig AL, Bamford L, Webel A, McCaul ME, Cachay ER, Jacobson JM, Saag MS, Kitahata MM, Crane HM, Williams EC. Ma J, et al. Among authors: mayer kh. AIDS Behav. 2024 Dec 3. doi: 10.1007/s10461-024-04566-x. Online ahead of print. AIDS Behav. 2024. PMID: 39625560 No abstract available.
Cabotegravir Maintains Protective Efficacy in the Setting of Bacterial STIs: A Secondary Analysis of HPTN 083.
Clement ME, Hanscom B, Haines D, Bazan JA, Chotirosniramit N, Kofron R, Mannheimer S, Mayer KH, Torres Silva MS, Soto-Torres L, Rinehart AR, Rooney JF, Jennings A, Gomez-Feliciano K, McCauley M, Grinsztejn B, Landovitz RJ; for HPTN 083 Study Team. Clement ME, et al. Among authors: mayer kh. Clin Infect Dis. 2024 Nov 23:ciae572. doi: 10.1093/cid/ciae572. Online ahead of print. Clin Infect Dis. 2024. PMID: 39579334
1,264 results